MEN1 and gastrin-producing neuroendocrine tumor: Previous studies on patients with MEN1 gastrinoma reported 10‐year survival rates of 88% to 100% regardless of therapy.7, 8, 11, 12, 13 Several factors could account for the different survival rates.